Good News For Consumers From Global Drug Manufacturers
U.S. residents pay too much for their prescription drugs and medical supplies, which reflects on our cost-plus reimbursement practice which is fueled through insurance reimbursement, whether government or private sector. This article reviews some pharmaceutical companies which are offering greater transparency and value for their products. Transparency from a Drug Manufacturer AstraZeneca, PLC, a UK pharmaceutical company recently published the results of its study on the blood thinner, Brillanta, which was used to prevent secondary heart attacks for stroke patients, and declared it performed no better than aspirin. [1] Stop the presses, this may not be a first, but it is unusual for a drug company to declare that its product is not effective, but then again this is in Europe where drug manufacturers can�t market their products directly to consumers and governments contract with pharmaceutical providers directly. This level of transparency should be encouraged in the U.S. where clinic...